The National Psoriasis Foundation issued a new position statement that clarifies the definition of psoriasis disease severity. The new criteria define psoriasis severity as “mild” or “moderate to ...

NEW YORK (Reuters Health) - People with severe forms of the inflammatory skin disease psoriasis are more likely to die of heart-related causes and stroke than those without the condition, new research ...

Although some people with plaque psoriasis can control their symptoms by using topical treatments that are applied to the skin, some people with moderate or severe plaque psoriasis do not get enough ...

The retrospective analysis, published in the Journal of Clinical Medicine, supports the use of tildrakizumab, an interleukin-23 (IL-23) inhibitor that was FDA approved in 2018 for moderate-to-severe ...

NEW YORK — No fewer than four investigative therapies, ranging from an oral interleukin-23 receptor antagonist to oral tyrosine kinase inhibitors and a long-acting biologic, have the potential to ...

Otezla (apremilast) is an oral tablet commonly used to treat plaque psoriasis in adults and children. Plaque psoriasis is an inflammatory skin condition that causes itchy, painful patches on the skin.

A 46-year-old man presents for his first dermatology consultation for worsening symptoms of plaque psoriasis and recent-onset joint pain. He reports “painful aching” and swelling of his finger joints, ...

Recent advances in molecular and pathobiology have brought the field of dermatology to the cusp of reaching a goal that seemed highly improbable or impossible just a few years ago: a cure for plaque ...